Naccache JM, Gibiot Q, Monnet I et al (2018) Lung cancer and interstitial lung disease: a literature review. J Thorac Dis 10:3829–3844. https://doi.org/10.21037/jtd.2018.05.75
Article PubMed PubMed Central Google Scholar
Kikuchi R, Takoi H, Tsuji T et al (2021) Glasgow prognostic score for prediction of chemotherapy-triggered acute exacerbation interstitial lung disease in patients with small cell lung cancer. Thorac Cancer 12:1681–1689. https://doi.org/10.1111/1759-7714.13900
Article CAS PubMed PubMed Central Google Scholar
Minegishi Y, Takenaka K, Mizutani H et al (2009) Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy. Intern Med 48:665–672
Sato T, Watanabe A, Kondo H et al (2015) Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases. J Thorac Cardiovasc Surg 149:64–69. https://doi.org/10.1016/j.jtcvs.2014.08.086
Xiaohong X, Liqiang W, Na L et al (2021) Management and prognosis of Interstitial lung disease with lung cancer (ILD-LC): a real-world cohort from three medical centers in China. Front Mol Biosci 8:660800. https://doi.org/10.3389/fmolb.2021.660800
Article PubMed PubMed Central Google Scholar
Ley B, Ryerson CJ, Vittinghoff E et al (2012) A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 156:684–691. https://doi.org/10.7326/0003-4819-156-10-201205150-00004.)
Ryerson CJ, Vittinghoff E, Ley B et al (2014) Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest 145:723–728. https://doi.org/10.1378/chest.13-1474
Sobin LH (2009) TNM classification of malignant tumors. Wiley-Blackwell, Chichester
Raghu G, Collard HR, Egan JJ et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824. https://doi.org/10.1164/rccm.2009-040GL
Article PubMed PubMed Central Google Scholar
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
Article PubMed PubMed Central Google Scholar
Sato T, Teramukai S, Kondo H et al (2014) Impact of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg 147:1604-1611.e3. https://doi.org/10.1016/j.jtcvs.2013.09.050
Chiyo M (2003) Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg 126:1141–1146. https://doi.org/10.1016/s0022-5223(03)00791-8
Watanabe T, Higami S, Ohori T et al (2008) Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J Thorac Cardiovasc Surg 136(1357–1363):1363.e1–2. https://doi.org/10.1016/j.jtcvs.2008.07.016
Kawaguchi T, Sawabata N, Miura S et al (2019) Prognostic impact of underlying lung disease in pulmonary wedge resection for lung cancer. Int J Clin Oncol 24:366–374. https://doi.org/10.1007/s10147-018-1367-3
Article CAS PubMed Google Scholar
Sekihar K, Aokage K, Oki T et al (2018) Long-term survival after complete resection of non-small-cell lung cancer in patients with interstitial lung disease. Interact Cardiovasc Thorac Surg 26:638–643. https://doi.org/10.1093/icvts/ivx400
Ichinokawa H, Takamochi K, Fukui M et al (2022) Outcome and prognosis of secondary lung cancer surgery with interstitial lung disease. Thorac Cancer 13:2024–2030. https://doi.org/10.1111/1759-7714.14481
Article CAS PubMed PubMed Central Google Scholar
Goodman CD, Nijman SFM, Senan S et al (2020) A primer on interstitial lung disease and thoracic radiation. J Thorac Oncol 15:902–913. https://doi.org/10.1016/j.jtho.2020.02.005
Yoshitake T, Nakamura K, Sasaki T et al (2015) Pulmonary interstitial changes is a predictive factor for radiation pneumonitis after stereotactic body radiation therapy for lung cancer patients. Int J Radiat Oncol Biol Phys 93:E416
Kobayashi H, Naito T, Omae K et al (2018) Impact of interstitial lung disease classification on the development of acute exacerbation of interstitial lung disease and prognosis in patients with stage III non-small-cell lung cancer and interstitial lung disease treated with chemoradiotherapy. J Cancer 9:2054–2060
Article PubMed PubMed Central Google Scholar
Ogura T, Takigawa N, Tomii K et al (2019) Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia. Respir Investig 57:512–533
Sekine A, Matama G, Hagiwara E et al (2022) Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy. Thorac Cancer 13:2443–2449. https://doi.org/10.1111/1759-7714.14566
Article CAS PubMed PubMed Central Google Scholar
Otsubo K, Okamoto I, Hamada N et al (2018) Anticancer drug treatment for advanced lung cancer with interstitial lung disease. Respir Investig 56:307–311. https://doi.org/10.1016/j.resinv.2018.03.002.)
Ohsawa M, Tsutani Y, Fujiwara M et al (2020) Predicting severe postoperative complication in patients with lung cancer and interstitial pneumonia. Ann Thorac Surg 109:1054–1060. https://doi.org/10.1016/j.athoracsur.2019.11.012.)
Mendonça Almeida L, Fernandes AL et al (2022) Mortality risk prediction with ILD-GAP index in a fibrotic hypersensitivity pneumonitis cohort. Ther Adv Respir Dis 16:17534666221135316. https://doi.org/10.1177/17534666221135316
Article CAS PubMed PubMed Central Google Scholar
Cao H, Huan C, Wang Q et al (2020) Predicting survival across acute exacerbation of interstitial lung disease in patients with idiopathic inflammatory myositis: the GAP-ILD model. Rheumatol Ther 7:967–978. https://doi.org/10.1007/s40744-020-00244-1
Article PubMed PubMed Central Google Scholar
Kobayashi H, Naito T, Omae K et al (2018) ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung disease. Lung Cancer 121:48–53. https://doi.org/10.1016/j.lungcan.2018.04.023
Ueno F, Kitaguchi Y, Shiina T et al (2020) The interstitial lung disease-gender-age-physiology index can predict the prognosis in surgically resected patients with interstitial lung disease and concomitant lung cancer. Respiration 99:9–18. https://doi.org/10.1159/000502849
Ki MS, Kim SY, Kim EY et al (2023) Clinical outcomes and prognosis of patients with interstitial lung disease undergoing lung cancer surgery: a propensity score matching study. Clin Lung Cancer 24:e27–e38
Tsutani Y, Mimura T, Kai Y et al (2017) Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease. J Thorac Cardiovasc Surg 154(1089–1096):e1. https://doi.org/10.1016/j.jtcvs.2017.03.116
Palma DA, Bahig H, Hope A et al (2024) Stereotactic radiation therapy in early non–small cell lung cancer and interstitial lung disease: a nonrandomized clinical trial. JAMA Oncol 10:575–582. https://doi.org/10.1001/jamaoncol.2023.7269
Comments (0)